Japanese emperor to take prostate MRI test in November | Inquirer News

Japanese emperor to take prostate MRI test in November

/ 04:36 PM October 03, 2022

Emperor Naruhito

FILE PHOTO: In this photo provided by the Imperial Household Agency of Japan, Japanese Emperor Naruhito speaks during a news conference at the Imperial Palace in Tokyo, Japan, February 21, 2022, ahead of the Emperor’s 62nd birthday on February 23. Mandatory credit Imperial Household Agency of Japan/Handout via REUTERS

TOKYO — Japanese Emperor Naruhito is set to take a magnetic resonance imaging (MRI) test in early November to check there is no disease in his prostate, the Imperial Household Agency (IHA) said in a statement on Monday.

Naruhito, 62, will take the MRI test after the result from a separate prostate-specific antigen (PSA) test showed values that were on a “somewhat concerning” trend, the agency said, without giving further details.

Article continues after this advertisement

Naruhito last month attended the funeral of Britain’s Queen Elizabeth together with Empress Masako in his first overseas trip since acceding to the throne in May 2019.

FEATURED STORIES

RELATED STORIES

Japanese Emperor Emeritus diagnosed with heart failure, condition improved

Article continues after this advertisement

Japan emperor hails Queen Elizabeth’s ‘many achievements’

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Emperor Naruhito, Japan, prostate, Royals

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.